Key result
PV-to-LA cycle length gradient <69% is linked to ~86% higher freedom from arrhythmia recurrence.
Why the study?
The role of pulmonary vein to left atrium cycle length gradient in predicting procedural and clinical outcomes of persistent AF ablation was unclear.
Does the pulmonary vein to left atrium cycle length gradient predict procedural and clinical outcomes in patients undergoing ablation for persistent atrial fibrillation?
Cohort (n=97)
Does the pulmonary vein to left atrium cycle length gradient predict procedural and clinical outcomes in patients undergoing ablation for persistent atrial fibrillation?
Absolute Event Rate: 80% vs 43%
p-value: p=<0.001
The pulmonary vein to left atrium cycle length gradient identifies patients with persistent atrial fibrillation who are likely to achieve AF termination and long-term freedom from recurrence after pulmonary vein isolation or limited substrate ablation.
PVfast/LAA ratio <69% was associated with higher arrhythmia-free survival after ablation; hypothesis-generating for risk stratification in persistent AF and requires prospective validation.
BACKGROUND: Rapid pulmonary vein (PV) activity has been shown to maintain paroxysmal atrial fibrillation (AF). We evaluated in persistent AF the cycle length (CL) gradient between PVs and the left atrium (LA) in an attempt to identify the subset of patients where PVs play an important role. METHODS AND RESULTS: Ninety-seven consecutive patients undergoing first ablation for persistent AF were studied. For each PV, the CL of the fastest activation was assessed over 1 minute (PVfast) using Lasso recordings. The PV to LA CL gradient was quantified by the ratio of PVfast to LA appendage (LAA) AF CL. Stepwise ablation terminated AF in 73 patients (75%). In the AF termination group, the PVfast CL was much shorter than the LAA CL resulting in lower PVfast/LAA ratios compared with the nontermination group (71±10% versus 92±7%; P<0.001). Within the termination group, PVfast/LAA ratios were notably lower if AF terminated after PV isolation or limited adjunctive substrate ablation compared with patients who required moderate or extensive ablation (63±6% versus 75±8%; P<0.001). PVfast/LAA ratio <69% predicted AF termination after PV isolation or limited substrate ablation with 74% positive predictive value and 95% negative predictive value. After a mean follow-up of 29±17 months, freedom from arrhythmia recurrence off-antiarrhythmic drugs was achieved in most patients with PVfast/LAA ratios <69% as opposed to the remaining population (80% versus 43%; P<0.001). CONCLUSIONS: The PV to LA CL gradient may identify the subset of patients in whom persistent AF is likely to terminate after PV isolation or limited substrate ablation and better long-term outcomes are achieved.
No takes yet. Share an insight, caveat, or question.
Pascale et al. (2014) conducted a cohort in Persistent atrial fibrillation (n=97). PVfast/LAA ratio <69% vs. PVfast/LAA ratio ≥69% (remaining population) was evaluated on Freedom from arrhythmia recurrence off-antiarrhythmic drugs (p=<0.001). A PV to LA cycle length gradient (PVfast/LAA ratio) <69% predicted higher freedom from arrhythmia recurrence off-antiarrhythmic drugs compared to the remaining population (80% vs 43%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: